The safety of obesity drugs.
Van Gaal
Luc F
LF
Scheen
André J
AJ
Formiguera
Xavier
X
D001067:Appetite Depressants / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D019964:Mood Disorders / Q000139:chemically induced / Q000523:psychology; D009765:Obesity / Q000188:drug therapy* / Q000523:psychology; D010880:Piperidines / Q000009:adverse effects / Q000494:pharmacology; D011720:Pyrazoles / Q000009:adverse effects / Q000494:pharmacology; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors; D000077285:Rimonabant
D001067:Appetite Depressants; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D000077285:Rimonabant